This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1979 Sep;5(9):1605-9.

doi: 10.1016/0360-3016(79)90782-x.

Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo

R K Johnson, I Wodinsky, J Swiniarski, K F Meaney, J J Clement

PMID: 583418
DOI: 10.1016/0360-3016(79)90782-x

Comparative Study

Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo

R K Johnson et al. Int J Radiat Oncol Biol Phys. 1979 Sep.

. 1979 Sep;5(9):1605-9.

doi: 10.1016/0360-3016(79)90782-x.

Authors

R K Johnson, I Wodinsky, J Swiniarski, K F Meaney, J J Clement

PMID: 583418
DOI: 10.1016/0360-3016(79)90782-x

No abstract available

PubMed Disclaimer

Similar articles

Combined therapy with an aziridine derivative NSC 200724 (AB182) and radiation on an experimental leukemia.
Wodinsky I, Clement J, Swiniarski J, Skura A. Wodinsky I, et al. Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1677-80. doi: 10.1016/0360-3016(79)90796-x. Int J Radiat Oncol Biol Phys. 1979. PMID: 536276 No abstract available.
Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
Johnson RK, Howard WS. Johnson RK, et al. Eur J Cancer Clin Oncol. 1982 May;18(5):479-87. doi: 10.1016/0277-5379(82)90117-1. Eur J Cancer Clin Oncol. 1982. PMID: 6956514 No abstract available.
Antitumour activity of some cyclophosphazenes.
Labarre JF, Faucher JP, Levy G, Sournies F, Cros S, François G. Labarre JF, et al. Eur J Cancer (1965). 1979 May;15(5):637-43. doi: 10.1016/0014-2964(79)90137-3. Eur J Cancer (1965). 1979. PMID: 510331 No abstract available.
[Current status of clinical results of new antitumor drugs].
Ogawa M. Ogawa M. Gan To Kagaku Ryoho. 1985 Feb;12(2):179-88. Gan To Kagaku Ryoho. 1985. PMID: 3918502 Review. Japanese.
Up-to-date improvements in inorganic ring systems as anticancer agents.
Labarre JF. Labarre JF. Top Curr Chem. 1982;102:1-87. doi: 10.1007/3-540-11345-2_7. Top Curr Chem. 1982. PMID: 6750846 Review. No abstract available.

See all similar articles

Cited by

The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2.
Roth I, Campbell H, Rubio C, Vennin C, Wilson M, Wiles A, Williams G, Woolley A, Timpson P, Berridge MV, Fleming N, Baird M, Braithwaite AW. Roth I, et al. Oncogene. 2016 Sep 22;35(38):4981-9. doi: 10.1038/onc.2016.45. Epub 2016 Mar 21. Oncogene. 2016. PMID: 26996665

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science